ESC 365 - Elamipretide in heart failure with reduced ejection fraction.

HFA Premium Access

Elamipretide in heart failure with reduced ejection fraction.

Session: Targeting mitochondria to improve outcomes in heart failure

Topic: Cell Signalling

Speaker: Professor H. Sabbah (Detroit, US)

Organised by Charité Medical School Berlin, supported by an unrestricted educational grant from Stealth Peptides

Event: HEART FAILURE 2016

Congress Presentation

Add to my library

About the speaker

Professor Hani Sabbah

Henry Ford Hospital, Detroit (United States of America)

3 presentations

0 follower

3 more presentations in this session

Reaching the next level of drug development for heart failure: targetting mitochondria.

Speaker: Professor S. Anker (Berlin, DE)

Elamipretide improves mitochondrial activity in the failing human heart.

Speaker: Doctor B. Stauffer (Aurora, US)

Clinical development concepts targeting mitochondria.

Speaker: Professor B. Pitt (Ann Arbor, US)

Access the full session

Targeting mitochondria to improve outcomes in heart failure

Speakers: Professor H. Sabbah, Professor S. Anker, Doctor B. Stauffer, Professor B. Pitt

About the event

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources